Medpace Holdings: Healthy Outsourcing Demand Supports Strong Growth; $227 Fair Value Estimate
Medpace Holdings Inc MEDP is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It is a full-service outsourcing model, providing services focused on the development, management and execution of clinical trials. As part of this full-service approach, the Company utilizes centralized systems, customer interface technology, support functions and processes that cross-service offerings and align resources to deliver efficient clinical trial services. It operates in North America, Europe, Africa, Asia, South America, Africa and Australia.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.